The prevalence of albuminuria among patients newly diagnosed with type 2 diabetes significantly dropped from 1988 to 2018, with improvements in glycemic, lipid control and blood pressure being reported among this population, according to a study in Diabetes Care. The researchers believed that "there have been improvements in diabetes screening and that we are diagnosing cases earlier in the disease process".